Characterization of Alzheimer Disease Biomarker Discrepancies Using P-tau and Positron Emission Tomography
This study characterizes individuals in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) data set with tau abnormality indicated by cerebrospinal fluid assay or positron emission tomography.
from journals https://ift.tt/2GdYENC
from journals https://ift.tt/2GdYENC
Comments
Post a Comment